From the June 2017 article:
Super important paragraph here discussing the specific vaccine-specific antibodies in Travelan and IMM-124 that set it apart from regular bovine colostrum and "are believed to provide the basis for the clinical protection afforded by HBC (today's Travelan and, perfected even more - specifically for inflammation - IMM-124E) in ETEC-challenged volunteers, which included reduced rate of illness (sure did...100% protection) and abdominal pain (reference #24 is Tacket's groundbreaking New England Journal of Medicine published study). The authors then go on to discuss other cross-reactive antibodies found in Travelan and IMM-124E that explain why it is effective against Shigella as well (see the Immuron/DoD NHP press release earlier this year).
- Forums
- ASX - By Stock
- Carol Tacket, Travelan, and the New England Journal of Medicine
From the June 2017 article:Super important paragraph here...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
9.9¢ |
Change
0.004(4.21%) |
Mkt cap ! $22.57M |
Open | High | Low | Value | Volume |
9.5¢ | 9.9¢ | 9.5¢ | $4.641K | 48.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3934 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 160371 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3934 | 0.095 |
4 | 112719 | 0.091 |
1 | 500000 | 0.090 |
1 | 11235 | 0.089 |
1 | 11363 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 160371 | 2 |
0.105 | 295769 | 3 |
0.110 | 96204 | 3 |
0.115 | 50000 | 1 |
0.120 | 138000 | 3 |
Last trade - 10.19am 10/09/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |